Garlanda Cecilia, Riva Federica, Veliz Tania, Polentarutti Nadia, Pasqualini Fabio, Radaelli Enrico, Sironi Marina, Nebuloni Manuela, Zorini Elisabetta Omodeo, Scanziani Eugenio, Mantovani Alberto
Istituto Clinico Humanitas (IRCCS), Rozzano, Italy.
Cancer Res. 2007 Jul 1;67(13):6017-21. doi: 10.1158/0008-5472.CAN-07-0560.
TIR8 (also known as SIGIRR) is a member of the interleukin-1/Toll-like receptor family with inhibitory activity on inflammatory reactions and high expression in intestinal mucosa. Here, we report that Tir8-deficient mice exhibited a dramatic intestinal inflammation in response to dextran sulfate sodium salt (DSS) administration in terms of weight loss, intestinal bleeding, and mortality and showed increased susceptibility to carcinogenesis in response to azoxymethane and DSS. Increased susceptibility to colitis-associated cancer was associated to increased permeability and local production of prostaglandin E(2), proinflammatory cytokines, and chemokines. Thus, these results are consistent with the hypothesis that TIR8, by negatively regulating intestinal inflammation, plays a nonredundant role in the control of the protumor activity of chronic inflammation in the gut.
TIR8(也称为SIGIRR)是白细胞介素-1/Toll样受体家族的成员,对炎症反应具有抑制活性,且在肠道黏膜中高表达。在此,我们报告,Tir8基因缺陷型小鼠在给予葡聚糖硫酸钠(DSS)后,在体重减轻、肠道出血和死亡率方面表现出剧烈的肠道炎症,并且对由氧化偶氮甲烷和DSS诱导的致癌作用敏感性增加。对结肠炎相关癌症易感性增加与通透性增加以及前列腺素E2、促炎细胞因子和趋化因子的局部产生有关。因此,这些结果与以下假设一致:TIR8通过负向调节肠道炎症,在控制肠道慢性炎症的促肿瘤活性中发挥非冗余作用。